IVF technology has developed for forty years of history, with the continuous progress of medical science and technology, IVF technology is also evolving, from the previous first generation of IVF, the second generation of IVF, and then to today's third generation of IVF, technology innovation can meet the patient's personalized fertility needs at the same time, but also to ensure the baby's health problems after birth, to achieve the true sense of eugenics.
Hengjian Overseas said that in today's ivy tube technology development is so mature, the success rate of test tubes continues to increase, there will still be many patients wondering: is the baby born by this test tube technology normal intelligence? What about social skills? What is your health? In fact, the majority of patients and friends do not have to worry about these problems, because the current third generation of test tube technology can screen abnormal genes, exclude genetic diseases, and achieve eugenics and eugenics, which is reliable. Of course, empty talk is hard to convince, the world's first case of IVF Louis. Brown, now in terms of life, social skills, intelligence and normal baby is not much different, the most important point is Louis. Brown also gave birth to babies through natural delivery. I believe this is enough to show that ivy and fertility technology is reliable! Of course, some of the following situations can also reflect from another level that the ivy technology to help fertility is really reliable!
1, the success rate, the success rate is the problem that every IVF family will care about, the success rate of each hospital is different, and there are many factors affecting the success rate of IVF, in addition to hospitals, doctors, but also with the patient's age, physical condition, infertility causes, living habits and so on. At present, the domestic test tube success rate is about 40%, while the Thai test tube success rate has been comparable to the United States, reaching 70%.
2. In terms of medical environment, hospital doctor services are better than domestic: the medical environment in China is worrying, and more than 80% are assembly line operation systems (there are many doctors in the course of treatment); The appointment time is longer, the procedures are cumbersome, and even more than half a year can be booked to the longer the time, to know that the higher the age of the patient, the age directly affects the success rate of the patient; Coupled with the low success rate, many patients are reluctant to undergo IVF fertility in China; However, it is different in ivy tube fertility: personalized service management system (one-on-one service, the whole course of treatment), the appointment time is simple, and it is much more convenient than domestic IVF fertility; A comfortable medical environment allows patients to rest assured, which will greatly improve the success rate of test tubes.
3. Regarding the use of IVF technology, domestic: the second generation of IVF fertility technology is generally followed, and a very small number of hospitals use three generations of technology (unless there is a family genetic disease). The world's leading third-generation test tube technology, PGD (Preimplantation Genetic Diagnosis) genetic screening technology can screen for genetic diseases (such as thalassemia, Down syndrome, cat syndrome, etc.) to achieve true eugenics.
Hengjian Overseas emphasizes here: the third generation of IVF technology: it is often said that the preimplantation genetic diagnosis/screening (PGD/PGS) technology is generally the detection of the number of chromosomes and structural abnormalities of embryos or blastocysts that develop to the 3rd or 5th day, and comprehensively screens and screens the 46 chromosomes of the embryo to prevent the occurrence of genetic diseases. In addition, this technology avoids complications and ethical problems such as bleeding, L birth and infection caused by traditional prenatal diagnostic techniques, and can also achieve the dual goals of improving the success rate of IVF-embryo transfer and reducing the incidence of birth defects.